Macérat glycériné de bourgeons de Myrtillier
Food supplement declared in France, declaration No 2024-3-184, decision dated 5 March 2024
Macérat glycériné de bourgeons de Myrtillier, from EI Marie Laresche, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium myrtillus 1.5 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- EI Marie Laresche
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 45 gouttes
- Directions for use
- 15 gouttes diluées dans l'eau avant chaque repas
- Intended populations
- People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Pregnant women, Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Blood and lymphatic circulation, Eye / Vision
Declaration 139720, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium myrtillus L. | Bourgeon | Extrait fluide hydroalcoolique | 1.5 ml |
Additives
E422
Other ingredients
Alcool éthylique, eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux enfants de moins de 10 ans et aux femmes enceintes.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Macérat glycériné de bourgeons de myrtillier Clémentine Benoit EI, declared in 2025 : different composition: 2 ingredient(s) added, 2 missing
- Macérat glycériné de bourgeons de Myrtillier La réserve de l'écureuil, declared in 2024 : different composition: 0 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Macérat glycériné de bourgeons de Myrtillier: composition and regulation”, https://compoatlas.com/en/supplements/products/139720-macerat-glycerine-de-bourgeons-de-myrtillier, updated 15 November 2026.